Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
TIOTROPIUM BROMIDE
B & S Healthcare
R03BB04
TIOTROPIUM BROMIDE
2.5 Base Micrograms
Solution for Inhalation
Product subject to prescription which may be renewed (B)
Anticholinergics
Authorised
2011-09-09
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. PACKAGE LEAFLET: INFORMATION FOR THE USER SPIRIVA ® RESPIMAT ® 2.5 MICROGRAM, SOLUTION FOR INHALATION (tiotropium) WHAT IS IN THIS LEAFLET 1. What Spiriva Respimat is and what it is used for 2. What you need to know before you take Spiriva Respimat 3. How to take Spiriva Respimat 4. Possible side effects 5. How to store Spiriva Respimat 6. Contents of the pack and other information 1. WHAT SPIRIVA RESPIMAT IS AND WHAT IT IS USED FOR Spiriva Respimat helps people who have chronic obstructive pulmonary disease (COPD) or asthma to breathe more easily. COPD is a long-term lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions chronic bronchitis and emphysema. Asthma is a long-term disease characterized by airway inflammation and narrowing of the airways. As COPD and asthma are long-term diseases you should take Spiriva Respimat every day and not only when you have breathing problems or other symptoms. When used to treat asthma you should use Spiriva Respimat in addition to so-called inhaled corticosteroids and long-acting ß 2 agonists. Spiriva Respimat is a long-acting bro Citiți documentul complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Spiriva Respimat 2.5 microgram, solution for inhalation 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The delivered dose is 2.5 microgram tiotropium per puff (2 puffs comprise one medicinal dose) and is equivalent to 3.124 microgram tiotropium bromide monohydrate. The delivered dose is the dose which is available for the patient after passing the mouthpiece. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Inhalation. _Product imported from Italy:_ Clear, colourless, solution for inhalation. 4 CLINICAL PARTICULARS As per PA0775/002/002 5 PHARMACOLOGICAL PROPERTIES As per PA0775/002/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Benzalkonium chloride Disodium edetate Water, purified Hydrochloric acid 3.6 % (for pH adjustment) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. In-use shelf life: 3 months 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not freeze. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 04/03/2016_ _CRN 2139300_ _page number: 1_ 6.5 NATURE AND CONTENTS OF CONTAINER Type and material of the container in contact with the medicinal product: Solution filled into a polyethylene/polypropylene cartridge with a polypropylene cap with integrated silicone sealing ring. The cartridge is enclosed within an aluminium cylinder. Pack sizes and devices supplied: Single pack: 1 Respimat inhaler and 1 cartridge, providing 60 puffs (30 medicinal doses) 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING Any unused product or waste ma Citiți documentul complet